Home > Income Statement > NATH BIOGENES (INDIA)

NATH BIOGENES (INDIA)
Total Expenditure

    Back to Income Statement
NATH BIOGENES (INDIA) is part of below Screeners ↓
Top Undervalued Small Cap Stocks
AD     Remove this Ad

NATH BIOGENES (INDIA) Last 5 Year Total Expenditure History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2013
Total Expenditure ₹315 Cr₹283 Cr₹252 Cr₹241 Cr₹118 Cr

What is the latest Total Expenditure of NATH BIOGENES (INDIA) ?

The latest Total Expenditure ratio of NATH BIOGENES (INDIA) is ₹315 Cr based on Mar2025 Consolidated results.
Year Total Expenditure
Mar2025₹315 Cr
Mar2024₹283 Cr
Mar2023₹252 Cr
Mar2022₹241 Cr
Mar2013₹118 Cr

How is Total Expenditure of NATH BIOGENES (INDIA) Trending?

Years Total Expenditure % Change
Mar2025 ₹315 Cr
11.42
Mar2024 ₹283 Cr
12.00
Mar2023 ₹252 Cr
4.66
Mar2022 ₹241 Cr
104.70
Mar2013 ₹118 Cr -

Compare Total Expenditure of peers of NATH BIOGENES (INDIA)

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA) ₹283.5 Cr 6.8% 3.6% -4.8% Stock Analytics
BOMBAY BURMAH TRADING CORPORATION ₹10,089.7 Cr 2.5% -10.8% -22% Stock Analytics
KAVERI SEED COMPANY ₹4,667.3 Cr 8.4% 21% -29.8% Stock Analytics
VENKYS (INDIA) ₹2,058.3 Cr 19.4% 13.8% -12.5% Stock Analytics
BOMBAY SUPER HYBRID SEEDS ₹1,018.1 Cr 11% 14.4% -12.9% Stock Analytics
INDO US BIOTECH ₹213.5 Cr 2.2% -5.6% -28.2% Stock Analytics


NATH BIOGENES (INDIA) Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
NATH BIOGENES (INDIA)

6.8%

3.6%

-4.8%

SENSEX

4.8%

-4.2%

0.8%


You may also like the below Video Courses